A structural keystone for drug design
3D-structures of proteins and potential ligands are the cornerstones of rational drug design. The first brick to build upon is selecting a protein target and finding out whether biologically active compounds are known. Both tasks require more information than the structures themselves provide. For t...
Main Authors: | Rother Kristian, Dunkel Mathias, Michalsky Elke, Trissl Silke, Goede Andrean, Leser Ulf, Preissner Robert |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2006-06-01
|
Series: | Journal of Integrative Bioinformatics |
Online Access: | http://www.degruyter.com/view/j/jib.2006.3.issue-1/biecoll-jib-2006-19/biecoll-jib-2006-19.xml?format=INT |
Similar Items
-
A structural keystone for drug design
by: Rother Kristian, et al.
Published: (2006-06-01) -
SuperLigands – a database of ligand structures derived from the Protein Data Bank
by: Preissner Robert, et al.
Published: (2005-05-01) -
SuperMimic – Fitting peptide mimetics into protein structures
by: Schmidt Ulrike, et al.
Published: (2006-01-01) -
Representation of target-bound drugs by computed conformers: implications for conformational libraries
by: Goede Andrean, et al.
Published: (2006-06-01) -
Columba: an integrated database of proteins, structures, and annotations
by: Preissner Robert, et al.
Published: (2005-03-01)